Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

S Lightman; S R J Taylor; C Bunce; H Longhurst; W Lynn; R Moots; M Stanford; O Tomkins-Netzer; D Yang; V L Calder; D O Haskard

doi:10.1136/annrheumdis-2014-205571

Article info

Clinical and epidemiological research

Extended report

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

Authors

S Lightman Moorfields Eye Hospital NHS Foundation Trust, London, UK UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles
S R J Taylor Moorfields Eye Hospital NHS Foundation Trust, London, UK Imperial College Healthcare NHS Trust, London, UK PubMed articles Google scholar articles
C Bunce Moorfields Eye Hospital NHS Foundation Trust, London, UK PubMed articles Google scholar articles
H Longhurst Barts Health NHS Trust, London, UK PubMed articles Google scholar articles
W Lynn Ealing Hospital NHS Trust, London, UK PubMed articles Google scholar articles
R Moots Aintree Hospitals NHS Trust, Liverpool, UK PubMed articles Google scholar articles
M Stanford GSTT NHS Foundation Trust, London, UK PubMed articles Google scholar articles
O Tomkins-Netzer Moorfields Eye Hospital NHS Foundation Trust, London, UK UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles
D Yang UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles
V L Calder UCL Institute of Ophthalmology, London, UK PubMed articles Google scholar articles
D O Haskard Imperial College Healthcare NHS Trust, London, UK PubMed articles Google scholar articles

Correspondence to Professor Sue Lightman, UCL Institute of Ophthalmology, Moorfields Eye Hospital, 162-165 City Road, London EC1V 2PD, UK; s.lightman{at}ucl.ac.uk

View Full Text

Citation

Lightman S, Taylor SRJ, Bunce C, et al

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

Annals of the Rheumatic Diseases 2015;74:1138-1144.

Publication history

Received March 14, 2014
Revised August 27, 2014
Accepted September 13, 2014
First published September 30, 2014.

Online issue publication

May 08, 2015

View clinical trial registration.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Copyright information

Read the full text or download the PDF:

Log in using your username and password